A Sustainable, Quality-by-Design (QbD) Inspired Spectrofluorimetric Method for the Concurrent Analysis of Cetirizine and Montelukast in COVID-19 and Allergic Rhinitis Combination Therapy.

El-Khateeb BZ, Amer MM, Michael MA

Open source

DOI
10.1002/bio.70632
Published
2026 Oct
Container
Luminescence : the journal of biological and chemical luminescence
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/bio.70632,
  title = {A Sustainable, Quality-by-Design (QbD) Inspired Spectrofluorimetric Method for the Concurrent Analysis of Cetirizine and Montelukast in COVID-19 and Allergic Rhinitis Combination Therapy.},
  author = {El-Khateeb BZ and Amer MM and Michael MA},
  year = {2026},
  journal = {Luminescence : the journal of biological and chemical luminescence},
  doi = {10.1002/bio.70632},
  url = {https://doi.org/10.1002/bio.70632}
}

RIS

TY  - JOUR
TI  - A Sustainable, Quality-by-Design (QbD) Inspired Spectrofluorimetric Method for the Concurrent Analysis of Cetirizine and Montelukast in COVID-19 and Allergic Rhinitis Combination Therapy.
AU  - El-Khateeb BZ
AU  - Amer MM
AU  - Michael MA
PY  - 2026
JO  - Luminescence : the journal of biological and chemical luminescence
DO  - 10.1002/bio.70632
UR  - https://doi.org/10.1002/bio.70632
ER  - 

APA

BZ, E., MM, A., & MA, M. (2026). A Sustainable, Quality-by-Design (QbD) Inspired Spectrofluorimetric Method for the Concurrent Analysis of Cetirizine and Montelukast in COVID-19 and Allergic Rhinitis Combination Therapy.. Luminescence : the journal of biological and chemical luminescence. https://doi.org/10.1002/bio.70632

Source records